Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Adenovirus-specific T-cells derived from allogeneic donor leukocytes, expanded ex vivo

EU orphan designation number: EU/3/13/1227   
Active ingredient: Adenovirus-specific T-cells derived from allogeneic donor leukocytes, expanded ex vivo
Indication: Treatment of adenovirus infection in allogeneic haematopoietic stem-cell transplant recipients
Sponsor: Cell Medica Ltd
1 Canal Side Studios, London, NW1 0QG, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/01/2014 Centralised Orphan - Designation EMA/OD/135/13 (2014)297 of 16/01/2014